|
Lamas-Paz A, Hionides-Gutierrez A, Guo F, Jorquera G, Moran-Blanco L, Benede-Ubieto R, Mesquita M, Estevez-Vazquez O, Zheng K, Mazariegos M, Vazquez-Ogando E, Blazquez-Lopez E, Asensio I, Mutlu B, Gomez-Santos B, Peligros MI, Vaquero J, Banares R, Delgado TC, Martinez-Chantar ML, Martinez-Naves E, Sanz-Garcia C, Mohamed MR, Tesolato S, Iniesta P, Gallego-Duran R, Maya-Miles D, Ampuero J, Romero-Gomez M, Martinez-Alcocer A, Sanfeliu-Redondo D, Fernandez-Iglesias A, Gracia-Sancho J, Coll M, Graupera I, Gines P, Ciudin A, Rivera-Esteban J, Pericas JM, Avila MA, Frutos MD, Martinez-Caceres CM, Ramos-Molina B, Aspichueta P, Puigserver P, Nevzorova YA, Cubero FJ. Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis. JHEP Rep. 2024 Oct 5;7(1):101230. doi: 10.1016/j.jhepr.2024.101230. eCollection 2025 Jan. PubMed PMID: 39659733; PubMed Central PMCID: PMC11629569.
AÑO: 2025; IF: 9.5
|
39659733
|
Xu K, Corona-Avila I, Frutos MD, Nunez-Sanchez MA, Makhanasa D, Shah PV, Guzman G, Ramos-Molina B, Priyadarshini M, Khan MW. Hepatic HKDC1 Deletion Alleviates Western Diet-Induced MASH in Mice. bioRxiv [Preprint]. 2025 Feb 27:2024.11.26.625530. doi: 10.1101/2024.11.26.625530. PubMed PMID: 39651120; PubMed Central PMCID: PMC11623584.
AÑO: 2025
|
|
Xu K, Corona-Avila I, Frutos MD, Nunez-Sanchez MA, Makhanasa D, Shah PV, Guzman G, Ramos-Molina B, Priyadarshini M, Khan MW. Hepatic HKDC1 deletion alleviates western diet-induced MASH in mice. Biochim Biophys Acta Mol Basis Dis. 2025 Apr;1871(4):167746. doi: 10.1016/j.bbadis.2025.167746. Epub 2025 Feb 27. PubMed PMID: 40020530.
AÑO: 2025; IF: 4.2
|
|
Martinez-Montoro JI, Martinez-Sanchez MA, Balaguer-Roman A, Fernandez-Ruiz VE, Hernandez-Barcelo JE, Ferrer-Gomez M, Frutos MD, Nunez-Sanchez MA, Fernandez-Garcia JC, Ramos-Molina B. Triglyceride to HDL Cholesterol Ratio for the Identification of MASLD in Obesity: A Liver Biopsy-Based Case-Control Study. Nutrients. 2024 Apr 27;16(9):1310. doi: 10.3390/nu16091310. PubMed PMID: 38732557; PubMed Central PMCID: PMC11085202.
AÑO: 2024; IF: 4.8
|
|
Nunez-Sanchez MA, Martinez-Sanchez MA, Sierra-Cruz M, Lambertos A, Rico-Chazarra S, Oliva-Bolarin A, Balaguer-Roman A, Yuste JE, Martinez CM, Mika A, Frutos MD, Llamoza-Torres CJ, Cordoba-Chacon J, Ramos-Molina B. Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction-associated steatotic liver disease. J Pathol. 2024 Sep;264(1):101-111. doi: 10.1002/path.6330. Epub 2024 Jul 18. PubMed PMID: 39022853; PubMed Central PMCID: PMC11300153.
AÑO: 2024; IF: 5.6
|